Psyber focuses on the development of brain-computer interface-enabled (BCI) digital therapeutics for treating mental health issues. On April 7th, 2021, ATAI Life Sciences acquired a majority stake in Psyber. The terms of the transaction were not disclosed.

Rocket Wellness is developing Digital Therapeutics (DTx) and wellness experiences that use mobile apps and virtual reality (VR) for the self-management of everyday life stressors.

EEG-based BCI devices record electrical activity in the brain for real-time interpretation of emotional, behavioural, and mental states. Rationale: We believe in giving patients more power during their therapeutic journey, while both improving and enhancing their therapeutic experience. How it works: Psyber empowers patients who are prescribed medication to achieve better mental health outcomes by offering personalized digitally enhanced, behaviour-changing experiences that complement their medication assisted therapy. Objective: Better outcomes, a better experience and better personalized behaviour change training than existing medication or behavioral therapy solutions currently offer.

Whether in the hospital or at home virtual reality therapeutic interventions offer improved treatment experiences and mental health outcomes. Unlike other digital approaches to mental well-being, which are often unengaging, non-measurable, and have high attrition rates our products allow users a new and improved way to care for their everyday mental well-being.